Tim Demuth
Chief Tech/Sci/R&D Officer bij MORPHOSYS AG
Profiel
Tim Demuth is currently the Chief Research & Development Officer at MorphoSys AG since 2022.
Prior to this, he was the Chief Medical Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. from 2021 to 2022.
He also held positions as VP & Head-Global Clinical Development Oncology at Merck KGaA and Head-Clinical Development at Sandoz AG.
Dr. Demuth obtained a doctorate degree from The Johannes Gutenberg University of Mainz.
Actieve functies van Tim Demuth
| Bedrijven | Functie | Begin |
|---|---|---|
| MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 01-10-2022 |
Eerdere bekende functies van Tim Demuth
| Bedrijven | Functie | Einde |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30-09-2022 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Opleiding van Tim Demuth
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| MORPHOSYS AG | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
